Global Automated Sample Storage Systems Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Automated Compound Storage System, Automated Liquid Handling Systems, and OthersBy Sample Type;
Biological Samples, Compound Samples, and OthersBy Application;
Biobanking, Pharmaceuticals, Clinical Research, and GenomicsBy End User;
Pharmaceutical & Biotechnology Companies, Academic Research Labs, Biobanks, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Automated Sample Storage Systems Market Overview
Automated Sample Storage Systems Market (USD Million)
Automated Sample Storage Systems Market was valued at USD 1,308.92 million in the year 2024. The size of this market is expected to increase to USD 2,648.25 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.5%.
Global Automated Sample Storage Systems Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 10.5 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 10.5 % |
Market Size (2024) | USD 1,308.92 Million |
Market Size (2031) | USD 2,648.25 Million |
Market Concentration | Low |
Report Pages | 386 |
Major Players
- Thermo Fisher Scientific, Inc.
- Beckman Coulter, Inc. (Danaher)
- Hamilton Company
- Azenta US, Inc.
- MEGAROBO
- SPT Labtech Ltd
- LiCONiC AG
- MICRONIC
- ASKION GmbH
- Haier Biomedical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Automated Sample Storage Systems Market
Fragmented - Highly competitive market without dominant players
The Automated Sample Storage Systems Market is witnessing substantial momentum, driven by the growing need for efficient and high-throughput sample handling. Automation is helping reduce manual errors and optimize lab workflows, especially in sectors like life sciences and pharmaceuticals, which contribute nearly 58% of the total demand for these systems.
Innovation Enhancing System Capabilities
Rapid advancements in robotics and artificial intelligence have significantly improved the functionality of automated storage systems, about 43% of these systems are integrated with cloud-based platforms, offering remote access, real-time monitoring, and advanced analytics, enabling smarter decision-making and compliance support.
Growing Use in Biobanking and Genomic Research
The need for secure, long-term preservation of biological samples is fueling adoption in biobanking and genomics, which now represent 36% of market usage. These systems help maintain strict environmental conditions and enhance retrieval precision, which is vital for storing sensitive biospecimens.
Boosting Laboratory Efficiency
Cost optimization and operational efficiency remain key growth factors. Automated systems reduce manual labor by approximately 40% and increase storage space efficiency by over 50%. These benefits make them indispensable for facilities managing large-scale sample inventories, while also helping reduce cross-contamination risks.
Automated Sample Storage Systems Market Recent Developments
-
In August 2022, a high-capacity biorepository was developed to store up to 10 million biospecimens, including blood, tissue, body fluids, and genetic materials, at ultra-low temperatures of -80°C.
-
In February 2022, Hamilton launched the Verso Q50 and Verso Q75 Automated Sample Storage Systems, offering up to 4x greater capacity than earlier models. These compact systems include redundant refrigeration and are designed for hands-free operation to improve lab efficiency.
Automated Sample Storage Systems Market Segment Analysis
In this report, the Automated Sample Storage Systems Market has been segmented by Product, Sample Type, Application, End User and Geography.
Automated Sample Storage Systems Market, Segmentation by Product
The Automated Sample Storage Systems Market has been segmented by Product into Automated Compound Storage System, Automated Liquid Handling Systems and Others.
Automated Compound Storage System
The automated compound storage system market is witnessing rapid growth, especially within pharmaceutical and biotech industries, due to its ability to maintain compound integrity and streamline storage workflows. Adoption has surged by over 40%, driven by demand for error-free, high-throughput operations. These systems offer superior temperature control, inventory accuracy, and are pivotal for long-term sample management.
Automated Liquid Handling Systems
Demand for automated liquid handling systems is rising, particularly in genomics and drug development. These systems enhance precision, consistency, and workflow speed, with over 35% increase in adoption across life sciences labs. By minimizing human intervention, they significantly improve reproducibility and efficiency in handling multiple assays and complex protocols.
Automated Sample Storage Systems Market, Segmentation by Application
The Automated Sample Storage Systems Market has been segmented by Application into Biobanking, Pharmaceuticals, Clinical Research, and Genomics.
Biobanking
The biobanking segment leads the automated sample storage systems market, contributing approximately 38% to the global share. These systems are crucial for the secure preservation of biological materials, offering advanced temperature control, inventory management, and regulatory compliance. Their role is vital in long-term biospecimen storage for research and diagnostics.
Pharmaceuticals
In pharmaceutical applications, automated sample storage systems streamline compound management and stability testing. Accounting for nearly 30% of the market, these systems support high-throughput drug discovery, minimize cross-contamination, and ensure data accuracy, accelerating R&D productivity across the sector.
Clinical Research
Automated storage systems in clinical research ensure sample integrity and uniform handling across studies. With a 20% market share, they help optimize trial workflows, enable real-time tracking, and support regulatory-compliant processes in large-scale clinical investigations.
Genomics
The genomics segment, with a market share of around 12%, benefits from automation to handle high volumes of DNA, RNA, and protein samples. These systems enhance scalability, accuracy, and efficiency, playing a critical role in next-generation sequencing and personalized medicine initiatives.
Automated Sample Storage Systems Market, Segmentation by End User
The Automated Sample Storage Systems Market has been segmented by End User into Pharmaceutical & Biotechnology Companies, Academic Research Labs, Biobanks and Others.
Pharmaceutical & Biotechnology Companies
Pharmaceutical and biotechnology companies dominate the automated sample storage systems market with an estimated 45% share. These organizations rely on automated storage to handle vast compound libraries, optimize drug discovery pipelines, and meet stringent regulatory requirements for sample integrity and traceability.
Academic Research Labs
Academic research labs contribute close to 20% of the market share, utilizing automation for efficient sample handling, data reproducibility, and laboratory productivity. These systems support complex experiments in genomics, molecular biology, and biomedical research, helping researchers streamline their workflows.
Biobanks
Biobanks, which account for nearly 25% of the market, depend on automation to safeguard sensitive biospecimens used in clinical research, population health studies, and personalized medicine. These systems offer secure, scalable, and compliant storage solutions crucial for long-term sample viability.
Automated Sample Storage Systems Market, Segmentation by Geography
In this report, the Automated Sample Storage Systems Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Automated Sample Storage Systems Market Share (%), by Geographical Region
North America
North America dominates the automated sample storage systems market, contributing nearly 40% of the total share. The region benefits from a well-established biotech and pharmaceutical sector, cutting-edge R&D infrastructure, and high demand for automated sample handling in both clinical and commercial applications.
Europe
With about 28% market share, Europe is a key region for automated storage technologies. Government support for biobanking, strict data compliance regulations, and a strong presence of academic research institutions are major growth drivers across the continent.
Asia Pacific
The Asia Pacific region is rapidly expanding, accounting for approximately 20% of the global market. Growth is fueled by increasing clinical research, rising investments in healthcare automation, and the presence of pharmaceutical manufacturing hubs in countries like China and India.
Middle East and Africa
The Middle East and Africa region holds around 6% market share. Ongoing efforts in healthcare digitization, biobank development, and increasing demand for laboratory automation are accelerating market growth in key areas such as the UAE, Saudi Arabia, and South Africa.
Latin America
Latin America captures nearly 6% of the global market. The region is witnessing a gradual increase in the adoption of automated systems in research institutions, driven by improving infrastructure, cross-border collaborations, and a growing emphasis on sample quality control.
Automated Sample Storage Systems Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Automated Sample Storage Systems Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunities Analysis
Drivers:
- Increasing Demand for Biobanking and Biorepository Solutions
- Advancements in Laboratory Automation and Robotics
-
Growing Biopharmaceutical Industry - The rapid expansion of the biopharmaceutical industry is playing a critical role in boosting the demand for automated sample storage systems. These storage solutions have become essential as pharmaceutical and biotech companies handle increasing volumes of biological samples used in drug development, quality testing, and research. With automation, laboratories gain enhanced efficiency, accuracy, and security in sample management, making it a valuable asset for modern drug pipelines.
Automated storage systems are capable of maintaining precise environmental conditions, ensuring the long-term viability and integrity of sensitive materials such as proteins, cell lines, and reagents. This capability is especially vital for companies developing biologics and biosimilars, where the slightest deviation in storage conditions can impact the outcome of R&D or clinical trials. The integration of these systems with digital tracking tools also enables better compliance and streamlined retrieval processes.
As the industry embraces data-intensive research and the shift toward personalized therapies, the need for organized, scalable, and secure sample repositories becomes more apparent. Automated systems support high-throughput research while minimizing human errors, contributing to faster and more reliable discoveries. They also help reduce labor costs and increase overall laboratory productivity.
With biopharmaceutical investments rising globally, particularly in emerging markets, the demand for intelligent and scalable storage infrastructure is expected to soar. Automated sample storage solutions have become a strategic necessity for organizations seeking long-term value and operational excellence in the competitive drug development landscape.
Restraints:
- High setup and operational costs
- Complex system maintenance requirements
- Limited awareness in smaller labs
-
Regulatory and compliance hurdles - Although automated sample storage systems offer numerous benefits, their adoption is often hindered by stringent regulatory and compliance requirements. Industries such as pharmaceuticals and healthcare are subject to rigorous standards that govern sample handling, data security, and traceability. Meeting these complex requirements often demands expensive system customization and lengthy validation processes, creating a barrier for many potential adopters.
Compliance with global standards such as GMP, GLP, and 21 CFR Part 11 requires storage systems to include detailed audit trails, robust temperature monitoring, and reliable backup systems. These features increase implementation complexity and cost. Additionally, companies must frequently update their infrastructure to stay aligned with evolving regulatory expectations, which can be resource-intensive.
The challenges are further amplified for multinational organizations due to differences in regulatory frameworks across regions. Navigating compliance requirements from agencies like the FDA, EMA, and other local bodies can lead to increased administrative burdens and delays in deployment. This inconsistency also limits the scalability of a single solution across global facilities.
Smaller institutions, startups, and academic research labs may struggle to afford these systems or view them as high-risk investments due to the fear of non-compliance. Despite their technological advantages, overcoming the regulatory challenges is a major concern that continues to restrain broader market penetration.
Opportunities:
- Rising Demand for Biobanking Solutions
- Expansion of Precision Medicine Initiatives
-
Emerging Applications in Regenerative Medicine and Cell Therapy - The emergence of regenerative medicine and cell therapy is unlocking new opportunities for the automated sample storage systems market. These cutting-edge fields rely heavily on the long-term preservation and traceability of valuable biological materials such as stem cells, tissue samples, and engineered cell lines. Automated systems ensure ultra-low temperature storage, contamination control, and sample integrity, which are essential for supporting clinical applications and translational research.
With the growing focus on cell-based therapies, researchers and clinicians are increasingly demanding storage solutions that are both efficient and compliant with strict quality standards. Automation not only secures sample preservation but also enhances workflow consistency and data transparency. This is critical in managing complex inventories and improving the reproducibility of experimental and clinical outcomes.
Automated storage systems are increasingly being integrated with biobanking platforms and laboratory information systems (LIS), allowing for seamless data management and improved accessibility. These features are invaluable for organizations working at the intersection of diagnostics, therapeutics, and clinical trials in regenerative medicine.
As investments in advanced therapies continue to rise, especially in stem cell and gene therapy sectors, the need for scalable, validated storage infrastructure will intensify. Automated systems are set to become the backbone of storage operations in this evolving landscape, offering a strategic edge in maintaining quality and accelerating innovation.
Automated Sample Storage Systems Market Competitive Landscape Analysis
Key players in Automated Sample Storage Systems Market include:
- Thermo Fisher Scientific, Inc.
- Beckman Coulter, Inc. (Danaher)
- Hamilton Company
- Azenta US, Inc.
- MEGAROBO
- SPT Labtech Ltd
- LiCONiC AG
- MICRONIC
- ASKION GmbH
- Haier Biomedical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Sample Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Automated Sample Storage Systems Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Demand for Biobanking and Biorepository Solutions
-
Advancements in Laboratory Automation and Robotics
-
Growing Biopharmaceutical Industry
-
- Restraints
-
High setup and operational costs
-
Complex system maintenance requirements
-
Limited awareness in smaller labs
-
Regulatory and compliance hurdles
-
- Opportunities
-
Rising Demand for Biobanking Solutions
-
Expansion of Precision Medicine Initiatives
-
Emerging Applications in Regenerative Medicine and Cell Therapy
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Automated Sample Storage Systems Market, By Product, 2021 - 2031 (USD Million)
-
Automated Compound Storage System
-
Automated Liquid Handling Systems
-
Others
-
- Automated Sample Storage Systems Market, By Sample Type, 2021 - 2031 (USD Million)
- Biological Samples
- Compound Samples
- Others
- Automated Sample Storage Systems Market, By Application, 2021 - 2031 (USD Million)
- Biobanking
- Pharmaceuticals
- Clinical Research
- Genomics
- Automated Sample Storage Systems Market, By End User, 2021 - 2031 (USD Million)
-
Pharmaceutical & Biotechnology Companies
-
Academic Research Labs
-
Biobanks
-
Others
-
- Automated Sample Storage Systems Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Automated Sample Storage Systems Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific, Inc.
- Beckman Coulter, Inc. (Danaher)
- Hamilton Company
- Azenta US, Inc.
- MEGAROBO
- SPT Labtech Ltd
- LiCONiC AG
- MICRONIC
- ASKION GmbH
- Haier Biomedical
- Company Profiles
- Analyst Views
- Future Outlook of the Market